AU531348B2 - 1,8 naphthyridine derivatives - Google Patents

1,8 naphthyridine derivatives

Info

Publication number
AU531348B2
AU531348B2 AU57519/80A AU5751980A AU531348B2 AU 531348 B2 AU531348 B2 AU 531348B2 AU 57519/80 A AU57519/80 A AU 57519/80A AU 5751980 A AU5751980 A AU 5751980A AU 531348 B2 AU531348 B2 AU 531348B2
Authority
AU
Australia
Prior art keywords
naphthyridine derivatives
naphthyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57519/80A
Other languages
English (en)
Other versions
AU5751980A (en
Inventor
Arthur Attilio Santilli
Anthony Carmen Scotese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU5751980A publication Critical patent/AU5751980A/en
Application granted granted Critical
Publication of AU531348B2 publication Critical patent/AU531348B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU57519/80A 1979-04-18 1980-04-16 1,8 naphthyridine derivatives Ceased AU531348B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3125579A 1979-04-18 1979-04-18
US31255 1979-04-18
US06/125,600 US4324893A (en) 1979-04-18 1980-02-28 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
US125600 1987-11-25

Publications (2)

Publication Number Publication Date
AU5751980A AU5751980A (en) 1980-10-23
AU531348B2 true AU531348B2 (en) 1983-08-18

Family

ID=26707004

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57519/80A Ceased AU531348B2 (en) 1979-04-18 1980-04-16 1,8 naphthyridine derivatives

Country Status (22)

Country Link
US (1) US4324893A (cg-RX-API-DMAC7.html)
EP (2) EP0018735B1 (cg-RX-API-DMAC7.html)
JP (1) JPS56500373A (cg-RX-API-DMAC7.html)
KR (1) KR840000076B1 (cg-RX-API-DMAC7.html)
AR (2) AR225437A1 (cg-RX-API-DMAC7.html)
AU (1) AU531348B2 (cg-RX-API-DMAC7.html)
CA (1) CA1115272A (cg-RX-API-DMAC7.html)
DK (1) DK537780A (cg-RX-API-DMAC7.html)
ES (1) ES490645A0 (cg-RX-API-DMAC7.html)
FI (1) FI801229A7 (cg-RX-API-DMAC7.html)
GB (1) GB2053198B (cg-RX-API-DMAC7.html)
GR (1) GR67253B (cg-RX-API-DMAC7.html)
HU (1) HU183125B (cg-RX-API-DMAC7.html)
IE (1) IE49696B1 (cg-RX-API-DMAC7.html)
IL (1) IL59667A (cg-RX-API-DMAC7.html)
IN (1) IN150969B (cg-RX-API-DMAC7.html)
NZ (1) NZ193445A (cg-RX-API-DMAC7.html)
PH (1) PH16524A (cg-RX-API-DMAC7.html)
PT (1) PT71081A (cg-RX-API-DMAC7.html)
SU (1) SU1131469A3 (cg-RX-API-DMAC7.html)
WO (1) WO1980002287A1 (cg-RX-API-DMAC7.html)
YU (1) YU105680A (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420615A (en) * 1981-08-24 1983-12-13 Merck & Co., Inc. Substituted pyridopyrimidines as gastric secretion inhibitors
FR2567520B1 (fr) * 1984-07-11 1987-01-02 Carpibem Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
NZ218773A (en) * 1986-01-06 1990-05-28 Carpibem 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions
FR2592650B1 (fr) * 1986-01-06 1988-04-29 Carpibem Nouvelles phenyl-naphtyridines fonctionnalisees en position-3, leur procede de preparation, medicaments les contenant, notamment anti-ulceres.
FR2592651B1 (fr) * 1986-01-06 1988-05-13 Carpibem Nouvelles phenyl naphtyridines comportant un substituant methyle en position 3, et les medicaments qui en contiennent.
FR2592652B1 (fr) * 1986-01-06 1988-04-29 Carpibem Nouvelles phenyl-naphtyridines, leur procede de preparation et les medicaments en contenant.
FR2592649B1 (fr) * 1986-01-06 1988-04-29 Carpibem Cyano et amido phenyl-naphtyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres.
NZ218774A (en) * 1986-01-06 1990-06-26 Carpibem 3-substituted phenylnaphthyridines and pharmaceutical compositions
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
EP0267691A3 (en) * 1986-10-15 1989-08-23 Schering Corporation Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity.
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
DK273689A (da) * 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
FR2632861B1 (fr) * 1988-06-15 1990-11-09 Sanofi Sa Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments
FR2632639B1 (fr) * 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
FR2637890B1 (fr) * 1988-09-14 1991-02-01 Europ Propulsion Materiau composite a matrice zircone
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR029185A1 (es) 1999-10-25 2003-06-18 Yamanouchi Pharma Co Ltd Derivado de naftiridina
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
KR20020092756A (ko) * 2001-06-05 2002-12-12 이종완 젓갈과 그 제조 방법
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2004091627A2 (en) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
MXJL06000006A (es) * 2003-08-22 2006-05-04 Avanir Pharmaceuticals Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
JP2008534502A (ja) 2005-03-24 2008-08-28 アバニール・ファーマシューティカルズ マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
CN113956252A (zh) 2017-09-28 2022-01-21 药捷安康(南京)科技股份有限公司 Pde9抑制剂及其用途
EA202190137A1 (ru) 2018-06-27 2021-05-17 Бристол-Маерс Сквибб Компани Нафтиридиноновые соединения для применения в качестве активаторов t-клеток
CN112654621B (zh) 2018-06-27 2024-05-14 百时美施贵宝公司 可作为t细胞活化剂的经取代萘啶酮化合物
AR119821A1 (es) 2019-08-28 2022-01-12 Bristol Myers Squibb Co Compuestos de piridopirimidinonilo sustituidos útiles como activadores de células t
AR120823A1 (es) 2019-12-23 2022-03-23 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como activadores de células t
KR20220120624A (ko) 2019-12-23 2022-08-30 브리스톨-마이어스 스큅 컴퍼니 T 세포 활성화제로서 유용한 치환된 피페라진 유도체
AU2020415377A1 (en) 2019-12-23 2022-08-18 Bristol-Myers Squibb Company Substituted quinazolinyl compounds useful as T cell activators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA947301A (en) * 1970-01-28 1974-05-14 Sumitomo Chemical Company Process for the preparation of compound having antibacterial action
CA988522A (en) * 1972-05-05 1976-05-04 Haydn W.R. Williams 1,8-naphthyridine compounds
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4103257A (en) * 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azaquinolone dye lasers
US4133885A (en) * 1977-07-18 1979-01-09 Merck & Co., Inc. Substituted naphthyridinones

Also Published As

Publication number Publication date
ES8104286A1 (es) 1981-04-16
AR227427A1 (es) 1982-10-29
AU5751980A (en) 1980-10-23
DK537780A (da) 1980-12-17
US4324893A (en) 1982-04-13
EP0018735B1 (en) 1983-07-27
NZ193445A (en) 1982-09-07
KR840000076B1 (ko) 1984-02-08
EP0018735A1 (en) 1980-11-12
IE800761L (en) 1980-10-18
HU183125B (en) 1984-04-28
SU1131469A3 (ru) 1984-12-23
IL59667A (en) 1983-11-30
EP0060012B1 (en) 1984-08-29
EP0060012A1 (en) 1982-09-15
YU105680A (en) 1983-09-30
JPS56500373A (cg-RX-API-DMAC7.html) 1981-03-26
FI801229A7 (fi) 1981-01-01
CA1115272A (en) 1981-12-29
AR225437A1 (es) 1982-03-31
IE49696B1 (en) 1985-11-27
WO1980002287A1 (en) 1980-10-30
ES490645A0 (es) 1981-04-16
KR830002759A (ko) 1983-05-30
GR67253B (cg-RX-API-DMAC7.html) 1981-06-26
PH16524A (en) 1983-11-10
PT71081A (en) 1980-05-01
GB2053198B (en) 1983-04-07
IN150969B (cg-RX-API-DMAC7.html) 1983-02-05
GB2053198A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
AU531348B2 (en) 1,8 naphthyridine derivatives
AU534288B2 (en) Naphthyridine derivatives
AU545756B2 (en) Alpha-alkyl-alpha-phenyl-1h-1,2,4-triazole-1-ethanols
AU533566B2 (en) Aminoalkylbenzene derivatives
AU541679B2 (en) Ergolinyl -n:,n:-diethylurea derivatives
AU516325B2 (en) Spiro-imidazolidinedione derivatives
AU529742B2 (en) Alkyl-ketohexopyranoside derivatives
AU529725B2 (en) Indolizine derivatives
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
AU5733380A (en) 6-arylpyrido(2,3-d)-pyrimidin-7-amines
AU5538280A (en) 1-azabicyclo (4,2,0) oct-2-em derivatives
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
AU534806B2 (en) 3-vinyl-cephalosporin derivatives
AU533797B2 (en) Thioethylamide derivatives
AU526214B2 (en) Pteridin derivatives
AU520245B2 (en) Glycerylphosphoryl derivatives
AU6494680A (en) 2,3-indoledione derivatives
AU530761B2 (en) Halo-vincamone derivatives
AU533484B2 (en) Tetrahydrochinoline derivatives
AU5538180A (en) 1-azabicyclo (4,2,0) oct-2-en derivatives
AU534308B2 (en) 15-hydroxyimino-e-homo-eburnane derivatives
AU531272B2 (en) 5-oxa-1-azabicyclo(4.1.0)oct-2-ene derivatives
AU518068B2 (en) 15-sulfonamidoprostaglandin derivatives
AU535319B2 (en) 1,2,4-imazine derivatives
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives